Vericel (VCEL) Net Margin (2011 - 2026)
Vericel recorded quarterly Net Margin of 9.31% in Q1 2026, down 135.85% quarter-over-quarter from 25.98% in Q4 2025, and up 1215.0% year-over-year from 0.71% in Q1 2025.
Vericel's Net Margin history runs 16 years deep, the most recent figure standing at 9.31% for Q1 2026.
- In Q1 2026, Net Margin rose 1215.0% year-over-year to 9.31%; the TTM figure through Mar 2026 stood at 7.65% (up 641.0% YoY), while the FY2025 annual figure was 5.98%, up 161.0% from the prior year.
- Net Margin came in at 9.31% for Q1 2026 at Vericel, down from 25.98% in the prior quarter.
- In the past five years, Net Margin ranged from a high of 26.28% in Q4 2024 to a low of 24.19% in Q2 2022.
- A 5-year average of 3.34% and a median of 8.03% in 2023 frame the typical range for Net Margin.
- Across the five-year window, Net Margin sank 1461 bps in 2022 and soared 1327 bps in 2023, its largest moves.
- Vericel's Net Margin stood at 11.24% in 2022, then surged by 78 bps to 19.99% in 2023, then surged by 31 bps to 26.28% in 2024, then retreated by 1 bps to 25.98% in 2025, then slumped by 136 bps to 9.31% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 9.31%, 25.98%, and 7.56% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 0.82% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 34.53% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 20.17% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 17.65% |
| 10 | Vericel | 1.69 Bn | 1.55 Bn | 49.27 Mn | -9.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.31% |
| Dec 31, 2025 | 25.98% |
| Sep 30, 2025 | 7.56% |
| Jun 30, 2025 | -0.84% |
| Mar 31, 2025 | -21.46% |
| Dec 31, 2024 | 26.28% |
| Sep 30, 2024 | -1.56% |
| Jun 30, 2024 | -8.88% |
| Mar 31, 2024 | -7.52% |
| Dec 31, 2023 | 19.99% |
| Sep 30, 2023 | -8.03% |
| Jun 30, 2023 | -10.92% |
| Mar 31, 2023 | -18.24% |
| Dec 31, 2022 | 11.24% |
| Sep 30, 2022 | -17.06% |
| Jun 30, 2022 | -24.19% |
| Mar 31, 2022 | -19.78% |
| Dec 31, 2021 | 9.53% |
| Sep 30, 2021 | -14.29% |
| Jun 30, 2021 | -9.58% |
| Mar 31, 2021 | -9.78% |
| Dec 31, 2020 | 27.02% |
| Sep 30, 2020 | 11.22% |
| Jun 30, 2020 | -41.32% |
| Mar 31, 2020 | -17.64% |
| Dec 31, 2019 | 24.19% |
| Sep 30, 2019 | 11.41% |
| Jun 30, 2019 | -75.61% |
| Mar 31, 2019 | -13.20% |
| Dec 31, 2018 | 24.93% |
| Sep 30, 2018 | -6.62% |
| Jun 30, 2018 | -24.25% |
| Mar 31, 2018 | -26.37% |
| Dec 31, 2017 | 8.50% |
| Sep 30, 2017 | -30.48% |
| Jun 30, 2017 | -16.62% |
| Mar 31, 2017 | -105.59% |
| Dec 31, 2016 | 5.43% |
| Sep 30, 2016 | -59.16% |
| Jun 30, 2016 | -38.88% |
| Mar 31, 2016 | -14.11% |
| Dec 31, 2015 | -32.12% |
| Sep 30, 2015 | -43.08% |
| Jun 30, 2015 | -16.62% |
| Mar 31, 2015 | -42.04% |
| Dec 31, 2014 | -15.86% |
| Sep 30, 2014 | -83.04% |
| Jun 30, 2014 | -192.24% |
| Dec 31, 2013 | -61,525.00% |
| Jun 30, 2013 | -162,966.67% |
| Mar 31, 2013 | -85,087.50% |
| Dec 31, 2012 | -41,605.26% |
| Mar 31, 2012 | -487,200.00% |
| Sep 30, 2011 | -21,488.89% |
| Mar 31, 2011 | -55,422.22% |